Skip to content

Subscriptions are live.

Plans

$NVS

Novartis AG

XNYSHealth CareUnknown

$159.88
-1.97%-$3.21
RVOL peak today
Normal
Halted today
None today
Float
1.78B
Next earnings
Oct 27 · in 53d
$159.88-1.97%$3.21Prev $163.09LIVE Full chart Live alerts
No recent price bars, the chart lights up when NVS starts printing.

Why is NVS down today? It is at $159.88 (-1.97%), and our scanner flagged it 46 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NVS spikes, and full due diligence on NVS — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $NVS alerts the moment volume spikes

Our scanner flagged $NVS 46 times in the last 30 days. Create a free account to track $NVS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$159.88
Change today
-1.97%
Previous close
$163.09
52-week range
$121.57 – $170.46
Valuation & dividend
Market cap
$330.58B
Dividend yield
2.91% ($4.74)
Ownership & volume
Shares outstanding
1.91B
SEC 20-F · Feb 4, 2026
Institutional own.
6.84%
Total held
6.8%
Tradeable float
1.78B
93% of shares · after 7% institutions
Short interest
5.0M
▼ -5% vs prior · as of 2026-08-14
Short % of float
0.3%
Days to cover
3.4d
Avg daily volume
1.8M
Next earnings
Oct 27 · in 53d
Classification
Sector
Health Care
Industry
Unknown
Exchange
XNYS
Relative volumevs this time of day
5m
0.9x
15m
0.7x
1h
0.7x
1D
0.3x

Get free NVS + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $NVS down today?

Fresh news

Here is the latest on NVS from our scanner (live price and day move above). A recent catalyst in the news: “Why Is Merck (MRK) Up 18.2% Since Last Earnings Report?.”

Likely catalystClinical / FDA update, from the latest SEC filing. Read it →
Why is $NVS moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profileShortableEasy to borrowNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusBuy4 analysts
Avg target $161.88(+1% upside)
Range $139 - $180
2 buy2 hold0 sell

Analyst data via Nasdaq. Not investment advice.

$NVS is down 2.0% today and has a recent share offering on file. See who may be selling into moves →

Dilution watch

Recent offering

Recent priced share offering — a one-time sale that has already completed (not ongoing). If $NVS runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.

$NVS Sentiment

Bullish
Bearish73Bullish
📰 News: 5 bull · 0 bearToday: -2.0%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$NVS Activity

News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

Alert· 21h ago +0.1% vs EMA
$NVS near 200 EMA: +0.08% from 200 EMA at 3:58 PM ET
at $163.00
Alert· 21h ago 87.6× RVOL
NVS hit 87.636x RVOL at 3:58 PM ET
at $163.00
News· Zacks Investment Research· 1d ago Neutral
Why Is Merck (MRK) Up 18.2% Since Last Earnings Report?
Alert· 1d ago -0.1% vs EMA
$NVS crossed below 200 EMA (-0.05% vs EMA) at 10:43 AM ET
at $162.34
Alert· 1d ago 19.5× RVOL
NVS hit 19.497x RVOL at 10:43 AM ET
at $162.34
Alert· 1d ago +0.0% vs EMA
$NVS near 200 EMA: +0.04% from 200 EMA at 10:14 AM ET
at $162.59
Alert· 1d ago 28.9× RVOL
NVS hit 28.916x RVOL at 10:14 AM ET
at $162.59
Alert· 1d ago
Novartis' Remibrutinib Delivers Positive Results in Late-Stage MS Studies
at $162.32
Alert· 1d ago 12.6× RVOL
NVS hit 12.631x RVOL at 3:57 PM ET
at $162.39
Alert· 1d ago 37.0× RVOL
NVS hit 37.009x RVOL at 3:31 PM ET
at $162.00
Alert· 1d ago +0.1% vs EMA
$NVS near 200 EMA: +0.08% from 200 EMA at 3:15 PM ET
at $161.84
Alert· 1d ago 10.4× RVOL
NVS hit 10.439x RVOL at 3:15 PM ET
at $161.84
Alert· 1d ago 54.5× RVOL
NVS hit 54.479x RVOL at 2:49 PM ET
at $161.60
Alert· 1d ago 7.9× RVOL
NVS hit 7.905x RVOL at 2:43 PM ET
at $161.43
News· Zacks Investment Research· 1d ago Bullish
Novartis' Remibrutinib Delivers Positive Results in Late-Stage MS Studies
Alert· 1d ago +0.0% vs EMA
$NVS near 200 EMA: +0.03% from 200 EMA at 2:17 PM ET
at $161.69
Alert· 1d ago 7.6× RVOL
NVS hit 7.616x RVOL at 2:17 PM ET
at $161.69
Alert· 1d ago 5.7× RVOL
NVS hit 5.720x RVOL at 1:47 PM ET
at $162.09
Alert· 2d ago +0.2% vs EMA
$NVS near 200 EMA: +0.16% from 200 EMA at 1:19 PM ET
at $161.73
Alert· 2d ago 44.7× RVOL
NVS hit 44.704x RVOL at 1:19 PM ET
at $161.73
joostihuffmeyer· 2d ago
added $NVS to their watchlist
Alert· 2d ago 27.7× RVOL
NVS hit 27.726x RVOL at 12:28 PM ET
at $161.61
Alert· 2d ago +0.0% vs EMA
$NVS near 200 EMA: +0.00% from 200 EMA at 12:15 PM ET
at $161.26
Alert· 2d ago 2.6× RVOL
NVS hit 2.607x RVOL at 12:15 PM ET
at $161.26
Alert· 2d ago 1530.4× RVOL
NVS hit 1530.360x RVOL at 11:49 AM ET
at $161.35
Alert· 2d ago +0.3% vs EMA
$NVS near 200 EMA: +0.34% from 200 EMA at 11:13 AM ET
at $161.68
Alert· 2d ago 30.3× RVOL
NVS hit 30.326x RVOL at 11:13 AM ET
at $161.68
Alert· 2d ago 33.8× RVOL
NVS hit 33.835x RVOL at 10:47 AM ET
at $161.24
News· SEC EDGAR· 3d ago
NOVARTIS AG filed a Foreign issuer report (6-K)
News· GlobeNewswire Inc.· 3d ago Bullish
Novartis remibrutinib, a high-efficacy oral BTK inhibitor, significantly reduces relapse rates and shows favorable safety profile in Phase III RMS trials
News· GlobeNewswire Inc.· 4d ago Bullish
Palmoplantar Pustulosis Market Report Now Available — Profiles AbbVie, Johnson & Johnson, Novartis, Amgen, UCB, and 4 Other Key Players, Segmented by Treatment Type and Distribution Channel
News· GlobeNewswire Inc.· 7d ago Bullish
Breast Cancer Therapeutics Market Size to Reach USD 95.14 Billion at a CAGR of 9.20% from 2035 – SNS Insider
News· GlobeNewswire Inc.· 10d ago Bullish
AI Poised to Reshape Blood Cancer Therapeutics as Investment Surges Past $2 Billion Across Leading Biotech and Pharma Players
News· GlobeNewswire Inc.· 10d ago Neutral
State of the Life Sciences Industry to Be Reviewed in BCC Research's 2026 Second Quarter Outlook, Spotlighting AI-Driven Discovery, Precision Oncology, and Connected Health Adoption

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

NVS stock FAQ

Why is $NVS down today?

Here is the latest on NVS from our scanner (live price and day move above). A recent catalyst in the news: “Why Is Merck (MRK) Up 18.2% Since Last Earnings Report?.”

What is the NVS stock price today?

NVS last traded at $159.88, down 1.97% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

When does NVS report earnings?

Novartis AG (NVS) is next expected to report earnings on Tuesday, October 27, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.

Does NVS pay a dividend?

Yes. NVS currently has a dividend yield of about 2.91% ($4.74 per share per year). Dividend figures can change; this is not investment advice.

Where can I see live NVS alerts?

The NVS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NVS 46 times in the last 30 days.

What exchange is NVS on?

NVS (Novartis AG) trades on XNYS, with a market cap of about $330.58B in the UNKNOWN sector.

Is NVS good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NVS for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.